Jod-Basedow phenomenon

Jod-Basedow phenomenon describes iodine-induced hyperthyroidism, most commonly seen in patients with pre-existing thyroid autonomy (e.g., multinodular goiter, subclinical Graves' disease, or iodine-deficient regions where thyroid tissue develops autonomous nodules). Normally, the thyroid gland regulates hormone synthesis via the Wolff-Chaikoff effect, in which high iodine intake transiently inhibits organification and hormone synthesis to protect against excess hormone production. However, in glands with autonomously functioning nodules or in Graves' disease, this autoregulatory mechanism is impaired, so a sudden iodine load provides substrate for unregulated thyroid hormone synthesis, precipitating thyrotoxicosis.

Clinical scenarios include administration of iodinated contrast media (CT scans), amiodarone therapy (which contains a large iodine load), consumption of iodine-rich seaweed, or iodine supplementation programs in populations with endemic iodine deficiency and pre-existing nodular goiters. Patients present with classic hyperthyroid symptoms: weight loss, palpitations, heat intolerance, tremor, anxiety, and tachycardia, sometimes triggered by recent iodine-containing imaging studies or medications.

Management involves recognizing the iodine exposure trigger, treating with beta-blockers for symptomatic control, and using thionamides (methimazole or PTU) to reduce thyroid hormone synthesis. In amiodarone-induced cases, distinguishing type 1 (Jod-Basedow, iodine-induced) from type 2 (destructive thyroiditis) amiodarone-induced thyrotoxicosis is important, as management differs (thionamides for type 1 vs corticosteroids for type 2).

This phenomenon is a classic USMLE topic often paired with the Wolff-Chaikoff effect to test understanding of iodine's dual role in thyroid physiology.